✦ LIBER ✦

An inhibitor of thymic hormone activity in serum from patients with lymphoblastic leukemia

✍ Scribed by J.J. Twomey; V.M. Lewis; R. Ford; G. Goldstein

Book ID: 115678116
Publisher: Elsevier Science
Year: 1980
Tongue: English
Weight: 472 KB
Volume: 68
Category: Article
ISSN: 1555-7162
DOI: 10.1016/0002-9343(80)90106-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An inhibitor of thymic hormone activity

An inhibitor of thymic hormone activity in serum from patients with lymphoblastic leukemia: Twomey JJ, Lewis VM, Ford R, Goldstein G: Am J Med 1980; 68: 377–380

📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Hypodiploidy of 37 chromosomes in an adu

Hypodiploidy of 37 chromosomes in an adult patient with acute lymphoblastic leukemia

✍ P.K. Das; P. Sharma; J. Koutts; A. Smith 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Very early onset of an acute myeloid leu

Very early onset of an acute myeloid leukemia in an adult patient with B-cell lymphoblastic leukemia

✍ V. SHIVAROV; A. STOIMENOV; I. GALABOVA; G. BALATZENKO; M. GUENOVA 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Glutathione peroxidase activities in ser

Glutathione peroxidase activities in serum and cerebrospinal fluid from patients with acute lymphocytic leukemia

✍ Ilker Durak; Solevman Büyükberber; Ömer Akvol; Orhan Canbolat; Mustafa Kavutçu; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 2 views

The management of hyperleukocytosis in a

The management of hyperleukocytosis in an adult patient with acute lymphoblastic leukemia and ataxia-telangiectasia

✍ Keklik, Muzaffer; Sivgin, Serdar; Kalin, Burhan Sami; Akyol, Gulsah; Pala, Cigde 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 171 KB

An evaluation of corynebacterium parvum

An evaluation of corynebacterium parvum during remission maintenance therapy in pediatric patients with acute lymphoblastic leukemia

✍ Lankford, J. ;Nitschke, R. ;Wells, J. ;Cox, C. ;Humphrey, G. B. 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 776 KB

The biologic impact and clinical toxicity of Corynebacterium parvum administered at a dose of 5 mg/M2 by intravenous or subcutaneous routes were evaluated in 18 children receiving combination chemotherapy for maintenance of acute lymphoblastic leukemia (ALL) in remission. Several nonspecific immunol